Literature DB >> 816140

Circulating IgG antibodies against factors IX and VIII in multiple sclerosis.

J L Moake, C J Kent, L D Meta, L C Wright.   

Abstract

A 64-year-old man with multiple sclerosis developed a circulating anticoagulant. Three immunoglobulin fractions (I = IgG; II =IgG+IgA; III = IgM) were separated from patient serum by 33-percent ammonium sulfate precipitation and DEAE-52 cellulose column chromatography. Fractions I (IgG) and II (IgG+IgA) had factor VIII inhibitory activity on incubation. Fraction I (IgG) possessed, in addition, immediate anti-IX activity which did not require incubation. Absorption studies characterized the VIII inhibitors as IgG-gamma in fraction I and IgG-gamma+IgG-lambda in fraction II. Immediately reactive IgG anti-IX antibodies associated with kinetically distinct IgG anti-VIII antibodies have not been described previously.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 816140     DOI: 10.1159/000207993

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  3 in total

1.  Symptomatic Acquired Haemophilia Due to Circulating Antibodies Against Both Factor VIII and IX in a Non-haemophiliac Patient.

Authors:  Sharat Damodar; Prashantha Bhat; Sitalakshmi Balasubramaniam
Journal:  Indian J Hematol Blood Transfus       Date:  2013-05-24       Impact factor: 0.900

2.  Development of acquired haemophilia A in a patient treated with alemtuzumab for multiple sclerosis.

Authors:  Jarrett Madeley; Georgina Hodges; Andrew Birchley
Journal:  BMJ Case Rep       Date:  2018-10-17

Review 3.  Coagulation Pathways in Neurological Diseases: Multiple Sclerosis.

Authors:  Nicole Ziliotto; Francesco Bernardi; Dejan Jakimovski; Robert Zivadinov
Journal:  Front Neurol       Date:  2019-04-24       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.